학술논문
#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER2-negative metastatic breast cancer
Document Type
article
Author
Source
Journal of Bone Oncology, Vol 45, Iss , Pp 100569- (2024)
Subject
Language
English
ISSN
2212-1374